Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Role: Corporate Counsel, Regulatory Location: Mechelen, Belgium (Hybrid - ad hoc visits to the office) Employment: Permanent Come build something that matters. It takes great people to achieve greatness. People with a sense of purpose and